Clinical Trial Update: Safety and Efficacy Study to Evaluate the Effect of SLV320 on Renal Function in Patients With Worsening Heart Failure [Phase 2]

View source ↗

Summary

A Phase 2 safety and efficacy trial of SLV320 in patients with Acute Decompensated Heart Failure and Renal Dysfunction has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Decompensated Heart Failure
• Renal Dysfunction

Drugs mentioned

• SLV320

Snippet

Sponsor: Solvay Pharmaceuticals | Conditions: Acute Decompensated Heart Failure; Renal Dysfunction | Phase 2 | Status: TERMINATED